Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_ffipsc197_promoter_n_RM_12_221_3			2	0.4	2.43E-04	GGN, ZNF670, DEAF1, MED24, TESC, NHP2L1, CBX7, ZFAT, GBX2	cell differentiation [BP], nucleus [CC]
CG_ffipsc197_promoter_n_RM_12_230_14			8	1.0	3.32E-04	BCL11B	striatal medium spiny neuron differentiation [BP], olfactory bulb axon guidance [BP]
CG_ffipsc197_promoter_n_RM_12_211_9			5	0.8	2.62E-04	DLG4, CLASP1, NR2F6, SEMA7A, FEZF1, MYH11	axon guidance [BP], neuron development [BP]
CG_ffipsc197_promoter_n_RM_12_192_4			2	0.4	1.70E-04	CLASP1	centrosomal corona [CC]
CG_ffipsc197_promoter_n_RM_12_218_7			6	1.0	2.83E-04	PENK, PYY	neuropeptide hormone activity [MF]
CG_ffipsc197_promoter_n_RM_12_89_4			2	0.4	2.37E-04	SLC35B2	3'-phosphoadenosine 5'-phosphosulfate transport [BP], 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [MF]
CG_ffipsc197_promoter_n_RM_14_3_2			5	0.8	2.49E-04	ODC1, STX1A	putrescine biosynthetic process from ornithine [BP], myosin head/neck binding [MF], ornithine decarboxylase activity [MF]
CG_ffipsc197_promoter_n_RM_12_82_5			4	0.8	3.69E-04	POU3F1, SMARCD3, SIX5, GLI3	sequence-specific DNA binding [MF], positive regulation of neuroblast proliferation [BP]
CG_ffipsc197_promoter_n_RM_12_7_5			5	0.8	3.98E-04	GRIN2A, GRIK3	glutamate receptor activity [MF], extracellular-glutamate-gated ion channel activity [MF], ionotropic glutamate receptor activity [MF]
CG_ffipsc197_promoter_n_RM_12_276_6			4	0.8	3.04E-04	PRMT5, GNB1	cardiac muscle cell apoptotic process [BP], cell proliferation [BP]
CG_ffipsc197_promoter_n_RM_12_179_11			6	1.0	3.51E-04	PIEZO1, PIEZO2	mechanically-gated ion channel activity [MF]
CG_ffipsc197_promoter_n_RM_12_258_7			5	0.8	3.69E-04	ICMT	protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF]
CG_ffipsc197_promoter_n_RM_12_227_5			3	0.6	4.64E-04	PAX8, NKX2-2	ventral spinal cord interneuron fate determination [BP], regulation of thyroid-stimulating hormone secretion [BP], type B pancreatic cell fate commitment [BP]
CG_ffipsc197_promoter_n_RM_12_195_8			4	0.8	3.33E-04	RERG, NOX4, EEF1E1, SIX5	negative regulation of cell proliferation [BP]
CG_ffipsc197_promoter_n_RM_12_137_2			2	0.4	2.77E-04	PLA2G16, ALAD, LBX1, NAGA, POU2F2, TREH	trehalose metabolic process [BP], porphobilinogen synthase activity [MF], regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP], lead ion binding [MF], alpha,alpha-trehalase activity [MF], oligosaccharide metabolic process [BP], alpha-N-acetylgalactosaminidase activity [MF], phosphatidylserine 1-acylhydrolase activity [MF], 1-acyl-2-lysophosphatidylserine acylhydrolase activity [MF], immunoglobulin secretion involved in immune response [BP], trehalose catabolic process [BP]
CG_ffipsc197_promoter_n_RM_18_3_1			2	0.4	3.93E-04	TNFRSF10D, PITX1	TRAIL binding [MF], myoblast cell fate commitment [BP], branchiomeric skeletal muscle development [BP]
CG_ffipsc197_promoter_n_RM_12_155_4			2	0.4	3.06E-04	LGR4, SIX4	positive regulation of branching involved in ureteric bud morphogenesis [BP]
CG_ffipsc197_promoter_n_RM_12_216_3			4	0.6	3.08E-04	IPMK	inositol tetrakisphosphate 3-kinase activity [MF], inositol-1,4,5-trisphosphate 6-kinase activity [MF]
CG_ffipsc197_promoter_n_RM_14_1_4			7	0.8	4.67E-04	MEX3D	mRNA localization resulting in posttranscriptional regulation of gene expression [BP]
CG_ffipsc197_promoter_n_RM_12_20_5			3	0.6	4.89E-04	ADAMTS8, BHLHE23	negative regulation of retinal cell programmed cell death [BP], post-embryonic eye morphogenesis [BP], low affinity phosphate transmembrane transporter activity [MF]
CG_ffipsc197_promoter_n_RM_12_157_5			6	0.8	3.32E-04	ATXN1	nuclear RNA export factor complex [CC]
CG_ffipsc197_promoter_n_RM_12_83_5			3	0.4	2.14E-04	ODC1, TSHZ3	putrescine biosynthetic process from ornithine [BP], ornithine decarboxylase activity [MF], ureteric peristalsis [BP]
CG_ffipsc197_promoter_n_RM_12_199_6			4	0.6	3.02E-04	APBB1, LRRC6	negative regulation of thymidylate synthase biosynthetic process [BP], diplotene [BP]
CG_ffipsc197_promoter_n_RM_12_213_5			4	0.6	3.27E-04	MPHOSPH6	M phase of mitotic cell cycle [BP]
CG_ffipsc197_promoter_n_RM_12_68_7			2	0.4	4.53E-04	LRP6, SAV1, TFRC	positive regulation of bone resorption [BP], ventricular septum morphogenesis [BP]
CG_ffipsc197_promoter_n_RM_12_262_2			4	0.8	4.60E-04	KDSR, PRDX3, LSS, CHST1, SRXN1, ITPK1	inositol-1,3,4-trisphosphate 6-kinase activity [MF], inositol-1,3,4-trisphosphate 5-kinase activity [MF], 3-dehydrosphinganine reductase activity [MF], sulfiredoxin activity [MF], oxidoreductase activity, acting on a sulfur group of donors [MF], alkyl hydroperoxide reductase activity [MF], inositol tetrakisphosphate 1-kinase activity [MF], keratan sulfotransferase activity [MF], lanosterol synthase activity [MF], 3-keto-sphinganine metabolic process [BP]
CG_ffipsc197_promoter_n_RM_12_238_7			5	0.8	2.60E-04	ONECUT1	epithelial cell development [BP]
CG_ffipsc197_promoter_n_RM_12_108_8			6	0.8	3.03E-04	EZH2, SURF6, PKLR	granular component [CC], pyruvate kinase activity [MF], histone H3-K27 methylation [BP]
CG_ffipsc197_promoter_n_RM_12_272_7			6	1.0	1.66E-04	BBC3, GNB2L1	positive regulation of intrinsic apoptotic signaling pathway [BP], positive regulation of protein homooligomerization [BP]
CG_ffipsc197_promoter_n_RM_12_254_5			2	0.4	3.90E-04	GALNS, GCH1	N-acetylgalactosamine-6-sulfatase activity [MF], GTP cyclohydrolase I activity [MF], N-acetylgalactosamine-4-sulfatase activity [MF], 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [BP], regulation of lung blood pressure [BP]
CG_ffipsc197_promoter_n_RM_12_81_4			3	0.6	3.46E-04	AXIN2, MCEE	L-methylmalonyl-CoA metabolic process [BP], methylmalonyl-CoA epimerase activity [MF], cellular response to organic cyclic compound [BP], regulation of chondrocyte development [BP]
CG_ffipsc197_promoter_n_RM_12_127_6			5	0.8	3.44E-04	PCYT2, NR3C1	glucocorticoid receptor activity [MF], ethanolamine-phosphate cytidylyltransferase activity [MF]
CG_ffipsc197_promoter_n_RM_12_72_4			2	0.4	1.03E-04	ERCC3, CDC42BPB, STX1A	nucleotide-excision repair, DNA duplex unwinding [BP], myosin head/neck binding [MF], synaptic vesicle membrane [CC], actomyosin [CC]
CG_ffipsc197_promoter_n_RM_12_274_4			3	0.6	3.08E-04	SPG20, DAP	cellular response to amino acid starvation [BP], negative regulation of collateral sprouting in absence of injury [BP]
CG_ffipsc197_promoter_n_RM_12_180_5			5	1.0	2.82E-04	HOXB3, SMAD2, FGF8, SLC23A1	thyroid gland development [BP], lung development [BP], organ growth [BP], mesoderm formation [BP], embryonic skeletal system morphogenesis [BP]
CG_ffipsc197_promoter_n_RM_14_5_4			4	0.6	4.09E-04	KCNK7, DNAJC1, DLL1, RAB3A, KCNB1, APBA1	ATPase activator activity [MF], synaptic transmission [BP], glutamate secretion [BP], cell-cell signaling [BP], nervous system development [BP]
CG_ffipsc197_promoter_n_RM_12_206_11			3	0.6	2.10E-04	CERS2, KLHL22, STAT5B, POU5F1, KLHL3, IL15RA, NFATC2	sequence-specific DNA binding [MF], positive regulation of natural killer cell differentiation [BP], transcription regulatory region DNA binding [MF], Cul3-RING ubiquitin ligase complex [CC], natural killer cell differentiation [BP]
CG_ffipsc197_promoter_n_RM_12_121_6			4	0.8	4.14E-04	MSC, MPP7, WT1, TAL1	cardiac muscle cell fate commitment [BP], positive regulation of protein complex assembly [BP], diaphragm development [BP]
CG_ffipsc197_promoter_n_RM_14_27_4			2	0.4	2.52E-04	TRMT2B, SLC25A11	alpha-ketoglutarate transport [BP], S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [MF], oxoglutarate:malate antiporter activity [MF]
CG_ffipsc197_promoter_n_RM_12_99_4			4	0.8	3.89E-04	NFIB, LEF1, IRF7, CALCOCO1, HOXA7	regulation of monocyte differentiation [BP], armadillo repeat domain binding [MF], positive regulation of transcription from RNA polymerase II promoter [BP], negative regulation of DNA binding [BP]
CG_ffipsc197_promoter_n_RM_12_275_8			5	0.8	4.02E-04	TARBP1, MESP1, DLL1	positive regulation of Notch signaling pathway [BP], negative regulation of endodermal cell fate specification [BP], positive regulation of Notch signaling pathway involved in heart induction [BP], cell fate determination [BP], cardiac atrium formation [BP], heart looping [BP], cardioblast migration to the midline involved in heart field formation [BP], cardioblast anterior-lateral migration [BP], sinus venosus morphogenesis [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_ffipsc197_promoter_n_RM_12_91_6			4	0.8	1.88E-04	TPT1, SOS1, PLEKHG5, PROK2, SIX2, PHIP, GPLD1, FGF8, BCAR1, ENTPD5	cell proliferation [BP], endothelial cell migration [BP], regulation of apoptotic process [BP], insulin receptor signaling pathway [BP], positive regulation of mitosis [BP], apoptotic process [BP], cellular response to insulin stimulus [BP]
CG_ffipsc197_promoter_n_RM_12_129_4			2	0.4	1.86E-04	UGGT2, PLOD3	procollagen glucosyltransferase activity [MF], UDP-glucose:glycoprotein glucosyltransferase activity [MF], UDP-glucosylation [BP]
CG_ffipsc197_promoter_n_RM_12_235_13			8	1.0	3.33E-04	RAP1GAP, DERL1, RRP8, CDC25C, MMS22L, CDC37, RRAS, RUNX3, ELOVL5, FANCC, SMNDC1, RP9, NACC2, TXNL4A, LZTFL1, SHARPIN, CIZ1	protein binding [MF]
CG_ffipsc197_promoter_n_RM_12_25_4			4	0.8	2.32E-04	GLO1, DPYD, CENPV, MKX, UCK1	tendon sheath development [BP], dihydropyrimidine dehydrogenase (NADP+) activity [MF], thymidine catabolic process [BP], UMP biosynthetic process [BP], lactoylglutathione lyase activity [MF], pyrimidine nucleobase metabolic process [BP], carbon-sulfur lyase activity [MF]
CG_ffipsc197_promoter_n_RM_12_93_6			5	1.0	3.59E-04	CLOCK, FOXA2	RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF]
CG_ffipsc197_promoter_n_RM_12_55_3			3	0.6	3.80E-04	GCNT4, MYBPC3, SLC23A1	C zone [CC], inter-male aggressive behavior [BP], dehydroascorbic acid transport [BP]
CG_ffipsc197_promoter_n_RM_12_185_6			4	0.8	2.31E-04	SUCLA2, STAT5B	succinate metabolic process [BP]
CG_ffipsc197_promoter_n_RM_12_249_7			2	0.4	2.77E-04	PDE2A, BCOR	negative regulation of tooth mineralization [BP], negative regulation of histone H3-K36 methylation [BP], negative regulation of histone H3-K4 methylation [BP], negative regulation of protein import into nucleus, translocation [BP]
CG_ffipsc197_promoter_n_RM_14_23_2			2	0.4	3.30E-04	OTUD7B, MAN2B1, PRC1	mitotic spindle elongation [BP], protein K11-linked deubiquitination [BP], protein deglycosylation [BP]
CG_ffipsc197_promoter_n_RM_14_9_3			3	0.6	3.15E-04	MAP4K1, NAGPA, FBXO5, NACC2	spindle assembly involved in female meiosis I [BP], N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [MF], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], inhibition of mitotic anaphase-promoting complex activity [BP], MAP kinase kinase kinase kinase activity [MF]
CG_ffipsc197_promoter_n_RM_12_231_5			4	0.8	3.99E-04	GFI1	auditory receptor cell differentiation [BP]
CG_ffipsc197_promoter_n_RM_16_1_3			9	1.0	4.26E-04	CELSR1, PODXL	epithelial tube formation [BP], regulation of microvillus assembly [BP], protein localization involved in establishment of planar polarity [BP]
CG_ffipsc197_promoter_n_RM_12_80_2			4	0.8	3.22E-04	PCDH8, SYNJ1, STX1A, MBOAT4, SCRIB	presynaptic membrane [CC], serine O-acyltransferase activity [MF], myosin head/neck binding [MF], peptidyl-serine octanoylation [BP], synaptic vesicle endocytosis [BP]
CG_ffipsc197_promoter_n_RM_12_200_6			2	0.4	1.96E-04	ZNF709, AFF4, FBXO43, FAF1, DPY30, MDC1, ID3, APBB2, NR4A2, ETS1, CYCS, CITED2, TRABD2A, NTHL1, HIVEP3, AGTPBP1, OLIG3, VEZF1, RGS17	nucleus [CC], response to fluid shear stress [BP], metabolic process [BP]
CG_ffipsc197_promoter_n_RM_12_171_10			4	0.6	3.35E-04	COL1A1, DLG4	dendritic spine morphogenesis [BP], tooth mineralization [BP]
CG_ffipsc197_promoter_n_RM_12_10_10			5	0.6	1.99E-04	AHCTF1, SEC13, DVL2, SPRY2, HOXA1, FOXN4, DUSP6, PDGFA	cochlea morphogenesis [BP], inner ear morphogenesis [BP], regulation of fibroblast growth factor receptor signaling pathway [BP], negative regulation of ERK1 and ERK2 cascade [BP], inner ear development [BP], embryo development [BP], nuclear pore outer ring [CC]
CG_ffipsc197_promoter_n_RM_12_138_4			5	1.0	2.82E-04	COBL	actin filament network formation [BP]
CG_ffipsc197_promoter_n_RM_12_245_8			3	0.6	2.67E-04	AXIN2	regulation of chondrocyte development [BP]
CG_ffipsc197_promoter_n_RM_12_184_4			6	1.0	2.49E-04	CHST15, CHST9	chondroitin sulfate biosynthetic process [BP]
CG_ffipsc197_promoter_n_RM_12_40_5			3	0.6	3.00E-04	DEGS2, DVL1, PRPSAP1, CIZ1, CDKN1C	maintenance of nucleus location [BP], sphingosine hydroxylase activity [MF], negative regulation of kinase activity [BP], negative regulation of protein binding [BP], enzyme inhibitor activity [MF], sphingolipid delta-4 desaturase activity [MF]
CG_ffipsc197_promoter_n_RM_14_21_2			2	0.4	2.69E-04	CD59	negative regulation of activation of membrane attack complex [BP]
CG_ffipsc197_promoter_n_RM_14_20_4			4	0.6	4.86E-04	TBX3	atrioventricular bundle cell differentiation [BP], sinoatrial node cell development [BP]
CG_ffipsc197_promoter_n_RM_12_107_15			1	0.2	4.98E-05	SRCIN1, TNFSF4, NT5C2	T-helper 2 cell activation [BP], chemokine (C-C motif) ligand 11 production [BP], interleukin-4-dependent isotype switching to IgE isotypes [BP], nucleoside phosphotransferase activity [MF], defense response to nematode [BP], memory T cell activation [BP], negative regulation of protein secretion [BP], positive regulation of CD4-positive, alpha beta T cell costimulation [BP]
CG_ffipsc197_promoter_n_RM_12_78_6			5	0.8	3.48E-04	TOP1MT, HMGB2	DNA topological change [BP]
CG_ffipsc197_promoter_n_RM_12_44_6			7	1.0	1.26E-04	DUSP6, TNIP1	negative regulation of ERK1 and ERK2 cascade [BP]
CG_ffipsc197_promoter_n_RM_12_232_5			5	1.0	2.25E-04	TPST2, MYO5A	peptidyl-tyrosine sulfation [BP], protein-tyrosine sulfotransferase activity [MF], endoplasmic reticulum localization [BP]
CG_ffipsc197_promoter_n_RM_12_159_8			4	0.8	2.29E-04	PIEZO1, PIEZO2	mechanically-gated ion channel activity [MF]
CG_ffipsc197_promoter_n_RM_12_193_5			3	0.6	2.38E-04	GSPT1	GTP catabolic process [BP]
CG_ffipsc197_promoter_n_RM_12_136_6			7	1.0	4.45E-04	OAT	ornithine-oxo-acid transaminase activity [MF]
CG_ffipsc197_promoter_n_RM_12_190_12			7	1.0	3.75E-04	DLG4, USP45, GRIK1, SMAD7, USP44, FKBP1A, HSP90AA1, ATG9B, USP46	ubiquitin-dependent protein catabolic process [BP], regulation of activin receptor signaling pathway [BP], transforming growth factor beta receptor binding [MF], regulation of excitatory postsynaptic membrane potential [BP], protein refolding [BP], type I transforming growth factor beta receptor binding [MF], ventricular cardiac muscle tissue morphogenesis [BP], cysteine-type peptidase activity [MF], ionotropic glutamate receptor complex [CC], ubiquitin-specific protease activity [MF], regulation of synaptic transmission, GABAergic [BP], cytoplasmic vesicle [CC], activin binding [MF], ubiquitin thiolesterase activity [MF]
CG_ffipsc197_promoter_n_RM_12_90_3			2	0.4	2.89E-04	GLRX2, DBR1	arsenate reductase (glutaredoxin) activity [MF], RNA lariat debranching enzyme activity [MF]
CG_ffipsc197_promoter_n_RM_12_210_8			4	0.8	2.36E-04	PPM1J, MTMR2, FBXW11	protein dephosphorylation [BP]
CG_ffipsc197_promoter_n_RM_12_149_6			5	0.8	2.28E-04	CNTFR	CNTFR-CLCF1 complex [CC]
CG_ffipsc197_promoter_n_RM_12_74_3			4	0.8	2.97E-04	COQ2, HAND1	embryonic heart tube formation [BP], 4-hydroxybenzoate decaprenyltransferase activity [MF], 4-hydroxybenzoate nonaprenyltransferase activity [MF]
CG_ffipsc197_promoter_n_RM_12_259_6			4	0.8	3.16E-04	PRKAG2, CDK5, RAPGEF3, CHST10	cAMP-dependent protein kinase regulator activity [MF], peptidyl-threonine phosphorylation [BP], HNK-1 sulfotransferase activity [MF], acetylcholine receptor activator activity [MF]
CG_ffipsc197_promoter_n_RM_16_3_2			6	0.8	4.63E-04	MGAT1, ADAM10	constitutive protein ectodomain proteolysis [BP], alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], UDP-N-acetylglucosamine catabolic process [BP]
CG_ffipsc197_promoter_n_RM_12_163_10			6	1.0	1.91E-04	HAND2, FASN	3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [MF], 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF], enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF], [acyl-carrier-protein] S-acetyltransferase activity [MF], 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF], positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis [BP], positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process [BP]
CG_ffipsc197_promoter_n_RM_16_2_6			9	1.0	4.32E-04	NKX3-2, GSK3B, PJA2	embryonic skeletal system development [BP], protein kinase A catalytic subunit binding [MF], positive regulation of Rac GTPase activity [BP]
CG_ffipsc197_promoter_n_RM_16_5_1			4	0.4	7.51E-05	ADAP1	inositol 1,3,4,5 tetrakisphosphate binding [MF]
CG_ffipsc197_promoter_n_RM_12_214_9			4	0.8	3.33E-04	CSNK1E, TRABD2A	negative regulation of Wnt receptor signaling pathway [BP]
CG_ffipsc197_promoter_n_RM_16_11_1			2	0.4	9.92E-04	VAMP2, TRIM27	clathrin-sculpted glutamate transport vesicle membrane [CC], negative regulation of interleukin-2 secretion [BP]
CG_ffipsc197_promoter_n_RM_12_75_4			2	0.4	3.45E-04	HSPD1, CEBPA, HOXB6, HOXB3, LBX2	embryonic skeletal system morphogenesis [BP], positive regulation of T cell mediated immune response to tumor cell [BP], response to vitamin B2 [BP], B cell cytokine production [BP], sequence-specific DNA binding [MF]
CG_ffipsc197_promoter_n_RM_12_220_4			4	0.8	1.71E-04	CTBP1, P4HB, SLC26A6, HDDC3, ALG3	dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [MF], guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF], formate transmembrane transporter activity [MF], endoplasmic reticulum-Golgi intermediate compartment [CC], regulation of transcription by chromatin organization [BP]
CG_ffipsc197_promoter_n_RM_12_26_4			2	0.4	4.35E-05	GRM6	new growing cell tip [CC]
CG_ffipsc197_promoter_n_RM_14_12_4			6	0.8	4.55E-04	TRMT61B, ODC1	mitochondrial tRNA methylation [BP], putrescine biosynthetic process from ornithine [BP], ornithine decarboxylase activity [MF]
CG_ffipsc197_promoter_n_RM_12_69_9			2	0.4	4.77E-04	FOXJ1, LDB1, MYL2, TWF1, IQSEC1	transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [BP], regulation of actin phosphorylation [BP], central tolerance induction [BP], actin cytoskeleton organization [BP], actin monomer binding [MF], negative regulation of humoral immune response mediated by circulating immunoglobulin [BP], glomerular parietal epithelial cell development [BP], muscle cell fate specification [BP], histone H3-K4 acetylation [BP], positive regulation of lung ciliated cell differentiation [BP], positive regulation of central B cell tolerance induction [BP]
CG_ffipsc197_promoter_n_RM_14_28_1			6	0.6	3.07E-04	PTGR1, DIAPH1	2-alkenal reductase [NAD(P)] activity [MF], cellular response to histamine [BP], 15-oxoprostaglandin 13-oxidase activity [MF], 13-prostaglandin reductase activity [MF]
CG_ffipsc197_promoter_n_RM_12_77_12			4	0.6	6.10E-04	IRF7, PCGF6, LEF1, SLC30A1, ATXN1, NFIB	negative regulation of mesenchymal cell proliferation involved in lung development [BP], negative regulation of zinc ion transmembrane import [BP], negative regulation of DNA binding [BP], regulation of MyD88-independent toll-like receptor signaling pathway [BP], negative regulation of transcription, DNA-dependent [BP], negative regulation of epithelial cell proliferation involved in lung morphogenesis [BP]
CG_ffipsc197_promoter_n_RM_12_71_3			4	0.6	1.49E-04	MDC1, WT1	glomerulus development [BP], FHA domain binding [MF], negative regulation of metanephric glomerular mesangial cell proliferation [BP]
CG_ffipsc197_promoter_n_RM_12_255_2			2	0.4	2.38E-04	SHOX2, CERS3, RAX, PCGF6, CEBPA	response to vitamin B2 [BP], sequence-specific DNA binding transcription factor activity [MF]
CG_ffipsc197_promoter_n_RM_12_151_6			6	1.0	5.57E-04	TUBGCP6, PNKP, CENPJ	gamma-tubulin small complex [CC], nucleotide phosphorylation [BP], microtubule nucleation [BP]
CG_ffipsc197_promoter_n_RM_12_225_4			3	0.6	2.48E-04	GNB1, ARRB1, NKX2-2	ventral spinal cord interneuron fate determination [BP], heterotrimeric G-protein complex [CC], type B pancreatic cell fate commitment [BP]
CG_ffipsc197_promoter_n_RM_12_168_5			4	0.8	2.48E-04	CHCHD4	protein import into mitochondrial intermembrane space [BP]
CG_ffipsc197_promoter_n_RM_12_267_10			7	1.0	2.83E-04	CKB, HR, OSBPL1A, SNRNP200, TP53TG5, DDX39A, GATM, STK24, FANCC, THYN1, TBX18, DAPK3, DPYSL3, KLK1, SRPK1, RPS6KA2, TAF4, PDZD7, STAT5B, PRKRIR, DEDD2, BCL2, RECQL4	response to axon injury [BP], germ cell development [BP], positive regulation of extrinsic apoptotic signaling pathway [BP], nucleus [CC], creatine metabolic process [BP]
CG_ffipsc197_promoter_n_RM_12_191_5			2	0.4	3.35E-04	GAMT, SMAD7, SIX1, TRIM27, PAWR, MKX, ITPK1	inositol tetrakisphosphate 1-kinase activity [MF], negative regulation of transcription from RNA polymerase II promoter [BP], inositol-1,3,4-trisphosphate 6-kinase activity [MF], guanidinoacetate N-methyltransferase activity [MF], inositol-1,3,4-trisphosphate 5-kinase activity [MF]
CG_ffipsc197_promoter_n_RM_12_212_4			3	0.6	2.99E-04	ADI1	acireductone dioxygenase [iron(II)-requiring] activity [MF]
CG_ffipsc197_promoter_n_RM_14_35_2			3	0.4	2.50E-04	RAB3D, DLG4, RP9	beta-1 adrenergic receptor binding [MF], peptidyl-cysteine methylation [BP], negative regulation of receptor internalization [BP], ATP-activated nucleotide receptor activity [MF], regulation of grooming behavior [BP], signal recognition particle receptor complex [CC], alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor clustering [BP], ADP-activated nucleotide receptor activity [MF], P2Y1 nucleotide receptor binding [MF]
CG_ffipsc197_promoter_n_RM_12_248_4			4	0.8	2.26E-04	IFNA2, NKX3-1, CBS, GCNT4	negative regulation of interleukin-5 secretion [BP], MADS box domain binding [MF], cystathionine beta-synthase activity [MF], inter-male aggressive behavior [BP], cysteine biosynthetic process via cystathionine [BP], negative regulation of interleukin-13 secretion [BP], positive regulation of androgen secretion [BP], homocysteine catabolic process [BP], cysteine biosynthetic process from serine [BP]
CG_ffipsc197_promoter_n_RM_12_61_8			3	0.6	2.88E-04	SMAD7, PCOLCE2, SYT15, GLI3	collagen binding [MF], extrinsic to membrane [CC], proximal/distal pattern formation [BP]
CG_ffipsc197_promoter_n_RM_12_281_5			3	0.6	2.27E-04	EPHA2, SLC23A1	notochord cell development [BP], dehydroascorbic acid transport [BP], regulation of blood vessel endothelial cell migration [BP]
CG_ffipsc197_promoter_n_RM_14_26_2			2	0.4	3.67E-04	SLC13A5	succinate transmembrane transporter activity [MF]
CG_ffipsc197_promoter_n_RM_12_181_6			5	1.0	1.97E-04	SFRP4, MAD1L1	mitotic telophase [BP], negative regulation of sodium-dependent phosphate transport [BP]
CG_ffipsc197_promoter_n_RM_12_253_5			6	1.0	3.88E-04	RNGTT, DBR1, HNRNPF, NKX3-1	MADS box domain binding [MF], polynucleotide 5'-phosphatase activity [MF], RNA lariat debranching enzyme activity [MF], mRNA splicing, via spliceosome [BP], positive regulation of androgen secretion [BP], RNA splicing, via transesterification reactions [BP], mRNA guanylyltransferase activity [MF]
CG_ffipsc197_promoter_n_RM_12_118_7			5	1.0	1.71E-04	CDKN2A, AFAP1L2, ACD, DAPK3, AKR7A3, CIDEB, CDKN2B	regulation of mitotic cell cycle [BP], induction of apoptosis [BP], aflatoxin catabolic process [BP], cyclin-dependent protein kinase inhibitor activity [MF], positive regulation of single-stranded telomeric DNA binding [BP], G1 phase of mitotic cell cycle [BP]
CG_ffipsc197_promoter_n_RM_14_16_3			3	0.4	3.50E-04	DAB1, RAB43, LAMA1	retinal blood vessel morphogenesis [BP], radial glia guided migration of Purkinje cell [BP], retrograde transport, plasma membrane to Golgi [BP], cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration [BP], laminin-3 complex [CC], cerebellum structural organization [BP]
CG_ffipsc197_promoter_n_RM_12_126_7			4	0.8	4.62E-04	TESK2, DSTYK	protein serine/threonine/tyrosine kinase activity [MF]
CG_ffipsc197_promoter_n_RM_12_38_6			4	0.8	3.35E-04	TBX3	atrioventricular bundle cell differentiation [BP], sinoatrial node cell development [BP]
CG_ffipsc197_promoter_n_RM_12_125_5			3	0.6	2.99E-04	NIN, MAP6D1	centrosome-templated microtubule nucleation [BP], N-terminal peptidyl-L-cysteine N-palmitoylation [BP]
CG_ffipsc197_promoter_n_RM_12_239_7			4	0.8	3.10E-04	CLDN6, WNT7B, CLDN5	calcium-independent cell-cell adhesion [BP], forebrain regionalization [BP]
CG_ffipsc197_promoter_n_RM_14_24_3			7	1.0	4.34E-04	NCAPD3, NCKAP1	basal protein localization [BP], establishment or maintenance of actin cytoskeleton polarity [BP], nuclear condensin complex [CC]
CG_ffipsc197_promoter_n_RM_12_175_11			3	0.4	4.32E-04	NCOA6, MYH9, NOTCH1, PIDD, HIRIP3, SMUG1	venous endothelial cell differentiation [BP], regulation of extracellular matrix assembly [BP], single-strand selective uracil DNA N-glycosylase activity [MF], Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP], nucleus [CC]
CG_ffipsc197_promoter_n_RM_14_14_3			7	1.0	1.58E-04	NAPB, NLRC4	SNARE complex disassembly [BP], pyroptosis [BP], IPAF inflammasome complex [CC]
CG_ffipsc197_promoter_n_RM_12_98_4			5	1.0	2.57E-04	INTS1, PRPF19	inner cell mass cell proliferation [BP]
CG_ffipsc197_promoter_n_RM_14_8_5			9	1.0	2.88E-04	MAP3K7, CARD10	activation of NF-kappaB-inducing kinase activity [BP]
CG_ffipsc197_promoter_n_RM_12_233_4			4	0.8	4.94E-05	RACGAP1	cytokinesis, actomyosin contractile ring assembly [BP], cytokinesis, initiation of separation [BP]
CG_ffipsc197_promoter_n_RM_12_160_5			6	0.8	2.26E-04	ERO1LB, MSRB1, PIGN, MGAT4B, MGAT1	post-translational protein modification [BP], alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], acetylglucosaminyltransferase activity [MF], oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [MF], methionine-R-sulfoxide reductase activity [MF], UDP-N-acetylglucosamine catabolic process [BP]
CG_ffipsc197_promoter_n_RM_12_285_4			2	0.4	1.97E-04	SIK1, WNT10B	positive regulation of anagen [BP], regulation of skeletal muscle tissue development [BP], myoblast cell differentiation involved in skeletal muscle regeneration [BP], negative regulation of triglyceride biosynthetic process [BP], skeletal muscle fiber development [BP]
CG_ffipsc197_promoter_n_RM_12_263_6			5	1.0	3.78E-04	CD70, NME3, SLC33A1, TNFRSF10B, PAX3, PLAGL2, PAWR, BBC3, JAG2	positive regulation of apoptotic process [BP], cell death [BP], intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [BP], induction of apoptosis [BP], regulation of apoptotic process [BP], apoptotic process [BP]
CG_ffipsc197_promoter_n_RM_12_88_5			6	1.0	3.04E-04	EFNB2	lymph vessel development [BP]
CG_ffipsc197_promoter_n_RM_12_49_4			2	0.4	2.54E-04	GALNT6, GALNT9, PNKP, ST3GAL2	protein O-linked glycosylation [BP], nucleotide phosphorylation [BP], post-translational protein modification [BP], O-glycan processing [BP], polypeptide N-acetylgalactosaminyltransferase activity [MF]
CG_ffipsc197_promoter_n_RM_14_32_5			4	0.6	2.67E-04	ST6GAL2, PKD1	beta-galactoside alpha-2,6-sialyltransferase activity [MF], metanephric distal tubule morphogenesis [BP]
CG_ffipsc197_promoter_n_RM_12_183_8			4	0.6	2.91E-04	WASL, SNRPB	cellular protein complex localization [BP], ncRNA metabolic process [BP]
CG_ffipsc197_promoter_n_RM_12_27_7			5	1.0	2.58E-04	STAR, IRS1, MESP1	cellular response to growth hormone stimulus [BP], positive regulation of striated muscle cell differentiation [BP], positive regulation of glucose metabolic process [BP]
CG_ffipsc197_promoter_n_RM_12_286_5			3	0.6	3.71E-04	DVL1, JAG2	morphogenesis of embryonic epithelium [BP], neuromuscular junction development [BP]
CG_ffipsc197_promoter_n_RM_12_246_5			2	0.4	3.59E-04	MYO1C, ZNF768, POLR2L	myosin I complex [CC], DNA-directed RNA polymerase II, core complex [CC], positive regulation of vascular endothelial growth factor signaling pathway [BP]
CG_ffipsc197_promoter_n_RM_12_164_13			7	0.8	2.12E-04	POLE2	DNA replication initiation [BP]
CG_ffipsc197_promoter_n_RM_12_32_7			4	0.6	1.93E-04	PDGFA, ASPM	negative regulation of asymmetric cell division [BP], regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP]
CG_ffipsc197_promoter_n_RM_12_162_7			4	0.6	3.00E-04	IL2RA	regulation of T cell homeostatic proliferation [BP]
CG_ffipsc197_promoter_n_RM_12_158_6			5	1.0	3.31E-04	SIAH2, UBE2N, RNF130, BCOR, RNF152, PTCH1, ACVR1	ubiquitin-protein ligase activity [MF], pharyngeal system development [BP], negative regulation of signal transduction [BP]
CG_ffipsc197_promoter_n_RM_12_145_6			4	0.8	3.34E-04	NRARP, BMP7	negative regulation of NF-kappaB import into nucleus [BP], negative regulation of Notch signaling pathway [BP]
CG_ffipsc197_promoter_n_RM_12_278_10			7	0.8	3.03E-04	NFIB, CEBPA, GCH1, DICER1, HDAC7, AKT1, NRL, EPHA2, TBX3, CBX8, NACC2, CUL7, KRAS, TGFBR3	positive regulation of fat cell differentiation [BP], vasculogenesis [BP], osteoblast differentiation [BP], negative regulation of transcription from RNA polymerase II promoter [BP], LRR domain binding [MF], positive regulation of establishment of protein localization to plasma membrane [BP], positive regulation of nitric-oxide synthase activity [BP], regulation of nitric-oxide synthase activity [BP], histone deacetylase activity [MF], blood vessel development [BP], striated muscle cell differentiation [BP], transcription from RNA polymerase II promoter [BP], regulation of blood vessel endothelial cell migration [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_ffipsc197_promoter_n_RM_12_19_6			2	0.4	2.32E-04	PCGF2, TOB2, EEF1D, DEAF1, REV3L, ZNF777, PITX2, POLR2L, WNT11, NR3C1	DNA binding [MF], ventricular septum morphogenesis [BP], adrenal gland development [BP], embryonic skeletal system development [BP], regulation of gene expression [BP], gene expression [BP]
CG_ffipsc197_promoter_n_RM_12_79_7			5	1.0	3.12E-04	COBL	floor plate development [BP]
CG_ffipsc197_promoter_n_RM_12_57_6			6	0.8	3.65E-04	ESR2, PDE2A, HOXA7, STAT5B, MKX, MYO10, FOXP1	regulation of cell adhesion [BP], core promoter sequence-specific DNA binding [MF], monocyte differentiation [BP], positive regulation of cell-cell adhesion [BP], sequence-specific DNA binding [MF]
CG_ffipsc197_promoter_n_RM_12_141_5			3	0.6	4.13E-04	LEF1, FEZF2, STAT5B	RNA polymerase II regulatory region sequence-specific DNA binding [MF], response to interleukin-4 [BP], dentate gyrus development [BP]
CG_ffipsc197_promoter_n_RM_14_39_2			4	0.6	2.83E-04	FOXL2	female somatic sex determination [BP], granulosa cell differentiation [BP], menstruation [BP], extraocular skeletal muscle development [BP]
CG_ffipsc197_promoter_n_RM_12_240_6			7	1.0	1.95E-04	IFT20, DYNC1LI2, PRICKLE1	positive regulation of protein ubiquitination [BP], centrosome localization [BP]
CG_ffipsc197_promoter_n_RM_12_148_8			5	0.8	2.40E-04	NODAL, NKX3-1, SHH, UGGT2, MYO10, LAMA1	prostate gland development [BP], transforming growth factor beta receptor signaling pathway involved in primitive streak formation [BP], mesenchymal smoothened signaling pathway involved in prostate gland development [BP], salivary gland development [BP], regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [BP], positive regulation of androgen secretion [BP], negative regulation of ureter smooth muscle cell differentiation [BP], nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [BP], inhibition of neuroepithelial cell differentiation [BP], UDP-glucosylation [BP], branching involved in salivary gland morphogenesis [BP], multicellular structure septum development [BP], epithelial cell proliferation involved in salivary gland morphogenesis [BP], branching morphogenesis of an epithelial tube [BP], positive regulation of kidney smooth muscle cell differentiation [BP], morphogen activity [MF], left lung development [BP], determination of left/right asymmetry in lateral mesoderm [BP], axial mesodermal cell fate specification [BP], MADS box domain binding [MF], lung development [BP], negative regulation of kidney smooth muscle cell differentiation [BP], regulation of embryonic development [BP], branching involved in prostate gland morphogenesis [BP], epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification [BP], positive regulation of skeletal muscle cell proliferation [BP], heart looping [BP], formation of anatomical boundary [BP], regulation of mesenchymal cell proliferation involved in prostate gland development [BP], positive regulation of cell-cell adhesion [BP], positive regulation of ureter smooth muscle cell differentiation [BP], epithelial tube branching involved in lung morphogenesis [BP], positive regulation of sclerotome development [BP]
CG_ffipsc197_promoter_n_RM_14_30_9			9	0.8	1.81E-04	WNT10B, WNT5A, PRPF8, CD2BP2	receptor agonist activity [MF], hematopoietic stem cell proliferation [BP], U5 snRNP [CC]
CG_ffipsc197_promoter_n_RM_12_29_7			3	0.6	6.57E-05	ITPK1	inositol tetrakisphosphate 1-kinase activity [MF], inositol-1,3,4-trisphosphate 6-kinase activity [MF], inositol-1,3,4-trisphosphate 5-kinase activity [MF]
CG_ffipsc197_promoter_n_RM_14_42_7			4	0.6	4.53E-04	NRIP1, ADAM10, CCDC6, DENND1A, DEDD2, PIAS2	androgen receptor binding [MF], SH3 domain binding [MF], positive regulation of extrinsic apoptotic signaling pathway [BP]
CG_ffipsc197_promoter_n_RM_12_242_9			6	0.8	2.26E-04	KLHL22, KLHL21	Cul3-RING ubiquitin ligase complex [CC]
CG_ffipsc197_promoter_n_RM_12_112_6			2	0.4	2.01E-04	HMGB2, SCRIB	positive chemotaxis [BP]
CG_ffipsc197_promoter_n_RM_12_33_18			5	0.8	4.15E-04	FANCG, FANCC, CDK6, NKX2-2, MLLT3, DRD1	Fanconi anaemia nuclear complex [CC], astrocyte differentiation [BP], astrocyte development [BP], segment specification [BP], dentate gyrus development [BP], type B pancreatic cell development [BP]
CG_ffipsc197_promoter_n_RM_12_36_3			5	0.8	2.95E-04	STX1B, TLE1, UBC, DVL1, CBX8, CBX7, OSBPL3, RHOA, MT1G, VAMP2, ADCY6	protein binding [MF], neurotransmitter transport [BP], methylated histone residue binding [MF], PRC1 complex [CC], PcG protein complex [CC], negative regulation of I-kappaB kinase/NF-kappaB cascade [BP]
CG_ffipsc197_promoter_n_RM_12_147_4			5	1.0	3.83E-04	CDK5, TUBB2B, PTHLH	negative regulation of synaptic plasticity [BP], mammary gland bud elongation [BP], neuron migration [BP], nipple sheath formation [BP], acetylcholine receptor activator activity [MF]
CG_ffipsc197_promoter_n_RM_12_265_6			6	1.0	4.34E-04	BCL6, HOXB3, SMAD7, NFATC2, HOXB5, HOXA5, PAX3, CITED2, PTCH1, NKX2-4, CEBPA	mammary gland epithelial cell differentiation [BP], sequence-specific DNA binding [MF], sequence-specific DNA binding transcription factor activity [MF]
CG_ffipsc197_promoter_n_RM_14_38_1			3	0.4	2.80E-05	LAMP3, RP9	signal recognition particle receptor complex [CC], alveolar lamellar body membrane [CC]
CG_ffipsc197_promoter_n_RM_12_43_7			6	1.0	3.90E-04	SCRIB, TUBB4A, STX2, FOXA1, CDK6, CIZ1, BID, PDGFA	mitotic cell cycle [BP], cell-cell junction [CC], myelin sheath [CC], response to estradiol stimulus [BP], cyclin binding [MF]
CG_ffipsc197_promoter_n_RM_12_169_4			4	0.6	2.28E-04	CLIP3	ganglioside binding [MF]
CG_ffipsc197_promoter_n_RM_12_54_13			6	1.0	3.37E-04	ASPH, DGKQ	response to ATP [BP]
CG_ffipsc197_promoter_n_RM_12_37_13			8	1.0	3.88E-04	SLC12A6, KEAP1	regulation of epidermal cell differentiation [BP], cellular hypotonic salinity response [BP]
CG_ffipsc197_promoter_n_RM_12_223_6			2	0.4	9.51E-05	TFRC, BUD13, DLG4, SLC19A1, FNBP1	RES complex [CC], P2Y1 nucleotide receptor binding [MF], methotrexate transport [BP], methotrexate transporter activity [MF], coated pit [CC]
CG_ffipsc197_promoter_n_RM_12_256_9			4	0.6	2.62E-04	PER1, CSDA, SLC25A11, NEUROG2	E-box binding [MF], positive regulation of cytoplasmic translation [BP], oxoglutarate:malate antiporter activity [MF]
CG_ffipsc197_promoter_n_RM_12_100_6			6	0.8	4.09E-04	FOXM1, SLC30A1, TP53BP2, PITX2	embryo development [BP], in utero embryonic development [BP], embryo development ending in birth or egg hatching [BP]
CG_ffipsc197_promoter_n_RM_12_114_3			4	0.6	3.73E-04	TSHZ3, PTCH1, GLI3, AKT1	ureteric bud development [BP], mammary gland epithelial cell differentiation [BP], negative regulation of smoothened signaling pathway [BP], osteoblast differentiation [BP], cell differentiation involved in kidney development [BP], thymocyte apoptotic process [BP], dorsal/ventral neural tube patterning [BP], metanephros development [BP]
CG_ffipsc197_promoter_n_RM_12_173_5			3	0.6	2.73E-04	BCAT2, IPMK	branched-chain amino acid biosynthetic process [BP], inositol tetrakisphosphate 3-kinase activity [MF], neural tube formation [BP], inositol-1,4,5-trisphosphate 6-kinase activity [MF], isoleucine catabolic process [BP]
CG_ffipsc197_promoter_n_RM_14_6_7			4	0.4	3.34E-04	TFAP2A	optic vesicle morphogenesis [BP], optic cup structural organization [BP]
CG_ffipsc197_promoter_n_RM_12_143_7			6	1.0	4.44E-04	LAMA4, PDGFB, MYO1E	blood vessel development [BP], glomerular filtration [BP], platelet-derived growth factor receptor signaling pathway [BP]
CG_ffipsc197_promoter_n_RM_12_120_5			9	1.0	3.02E-04	DIMT1, NCR3, TEX10, TCEA1, STAT5B, HNRNPA2B1, RBM19, SIN3A, EDF1	positive regulation of natural killer cell mediated cytotoxicity [BP], nucleolus [CC]
CG_ffipsc197_promoter_n_RM_12_139_5			4	0.6	2.08E-04	RRP9	small nucleolar ribonucleoprotein complex [CC]
CG_ffipsc197_promoter_n_RM_12_156_6			3	0.6	2.60E-04	SHPK	regulation of macrophage activation [BP]
CG_ffipsc197_promoter_n_RM_12_85_12			2	0.4	3.69E-04	DNMT1, DNAJC1, RAB3A, BAZ1B	centromeric heterochromatin [CC], ATPase activator activity [MF]
CG_ffipsc197_promoter_n_RM_12_95_8			3	0.6	1.65E-04	TK1, ANKLE2	mitotic nuclear envelope reassembly [BP], fetal process involved in parturition [BP]
CG_ffipsc197_promoter_n_RM_14_11_3			5	0.8	2.53E-04	FAM109A, AP4B1, SMPD4	sphingomyelin phosphodiesterase D activity [MF], trans-Golgi network [CC]
CG_ffipsc197_promoter_n_RM_12_122_11			5	1.0	5.25E-04	TFAP2A, SAV1, MTF1	RNA polymerase II core promoter sequence-specific DNA binding [MF], response to metal ion [BP], keratinocyte differentiation [BP]
CG_ffipsc197_promoter_n_RM_14_34_2			1	0.2	3.81E-04	PCYT2	ethanolamine-phosphate cytidylyltransferase activity [MF]
CG_ffipsc197_promoter_n_RM_12_102_5			5	0.8	2.84E-04	FANCL, PMVK, DHCR7, XPO1	nuclear envelope [CC], cholesterol biosynthetic process [BP]
CG_ffipsc197_promoter_n_RM_12_177_8			6	1.0	2.89E-04	PARD3, PIP4K2A, MYO10, PIP4K2B	1-phosphatidylinositol-5-phosphate 4-kinase activity [MF], phosphatidylinositol-3,4,5-trisphosphate binding [MF], 1-phosphatidylinositol-4-phosphate 5-kinase activity [MF]
CG_ffipsc197_promoter_n_RM_12_96_12			7	0.8	3.53E-04	SALL1, SSU72, GAS1, IMPAD1, CPSF1, HSPG2	mRNA 3'-end processing [BP], embryonic digit morphogenesis [BP], negative regulation of smoothened signaling pathway [BP], mRNA polyadenylation [BP], endochondral ossification [BP], outer ear morphogenesis [BP]
CG_ffipsc197_promoter_n_RM_12_280_3			2	0.4	2.57E-04	PLOD3, LBX1, PTGR1, EDF1	2-alkenal reductase [NAD(P)] activity [MF], procollagen glucosyltransferase activity [MF], regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP], endothelial cell differentiation [BP]
CG_ffipsc197_promoter_n_RM_14_29_3			10	1.0	2.53E-04	CIZ1, TRPT1	tRNA 2'-phosphotransferase activity [MF], maintenance of nucleus location [BP]
CG_ffipsc197_promoter_n_RM_12_50_10			2	0.4	3.15E-04	MB21D1, HEY1, BAD	atrioventricular valve formation [BP], cyclic-GMP-AMP synthase activity [MF], cellular response to chromate [BP]
CG_ffipsc197_promoter_n_RM_12_165_4			4	0.6	3.40E-04	RPS6KA5, PEMT, SLC33A1, SLC25A11, HEY1, INTS1	acetyl-CoA transporter activity [MF], acetyl-CoA transport [BP], atrioventricular valve formation [BP], phosphatidylethanolamine N-methyltransferase activity [MF], U2 snRNA 3'-end processing [BP], histone H2A-S1 phosphorylation [BP], phosphatidyl-N-dimethylethanolamine N-methyltransferase activity [MF], phosphatidyl-N-methylethanolamine N-methyltransferase activity [MF], oxoglutarate:malate antiporter activity [MF]
CG_ffipsc197_promoter_n_RM_12_282_4			3	0.6	2.03E-04	MGAT1, GLI3, SLC6A4, GABBR1	anterior semicircular canal development [BP], lambdoid suture morphogenesis [BP], serotonin:sodium symporter activity [MF], lateral semicircular canal development [BP], sagittal suture morphogenesis [BP], lateral ganglionic eminence cell proliferation [BP], cocaine binding [MF], negative regulation of cerebellar granule cell precursor proliferation [BP], G-protein coupled receptor dimeric complex [CC], alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], UDP-N-acetylglucosamine catabolic process [BP]
CG_ffipsc197_promoter_n_RM_12_154_3			3	0.6	3.25E-04	NUDT18	GDP catabolic process [BP], 8-oxo-dGDP phosphatase activity [MF], 8-oxo-GDP phosphatase activity [MF], dADP catabolic process [BP], dGDP catabolic process [BP], 8-hydroxy-dADP phosphatase activity [MF]
CG_ffipsc197_promoter_n_RM_12_76_8			5	1.0	2.77E-04	SLC16A6	monocarboxylic acid transmembrane transporter activity [MF]
CG_ffipsc197_promoter_n_RM_16_8_1			2	0.4	6.27E-04	AXIN2, TBX18	regulation of mismatch repair [BP], negative regulation of canonical Wnt receptor signaling pathway [BP], negative regulation of canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], somitogenesis [BP], regulation of chondrocyte development [BP]
CG_ffipsc197_promoter_n_RM_12_250_9			6	0.8	5.07E-04	HIRA	osteoblast differentiation [BP]
CG_ffipsc197_promoter_n_RM_12_23_5			6	0.8	1.76E-04	ANKRD54, EXOSC3, MEF2D, BHLHE23, IMPDH1, TNIP2, SFMBT1, TRIM66, MAF, SIK1, ZNF503, CERK, PRKD2, NCOA6	positive regulation of transcription from RNA polymerase II promoter [BP], nucleus [CC]
CG_ffipsc197_promoter_n_RM_12_39_6			7	1.0	4.84E-04	HSP90AA1, DNAJB1, HLA-DMA, APOA4	response to unfolded protein [BP], protein refolding [BP], chaperone mediated protein folding requiring cofactor [BP], removal of superoxide radicals [BP]
CG_ffipsc197_promoter_n_RM_12_182_10			3	0.6	3.90E-04	HOXA1	optokinetic behavior [BP], abducens nerve formation [BP]
CG_ffipsc197_promoter_n_RM_12_132_6			2	0.4	3.03E-04	CDK5	acetylcholine receptor activator activity [MF]
CG_ffipsc197_promoter_n_RM_12_106_6			6	0.8	3.36E-04	CBX4	enzyme binding [MF]
CG_ffipsc197_promoter_n_RM_12_113_8			5	0.8	2.48E-04	BBC3, ADRA2B, WNT5A	activation of protein kinase B activity [BP], positive regulation of thymocyte apoptotic process [BP]
CG_ffipsc197_promoter_n_RM_14_19_3			7	1.0	1.98E-04	MYH9, RGS10, CHD8	DNA helicase activity [MF], termination of G-protein coupled receptor signaling pathway [BP], DNA-dependent ATPase activity [MF]
CG_ffipsc197_promoter_n_RM_12_161_6			8	1.0	4.39E-04	ZFP36L2, FEV, STAT5B, NEUROG1, PAXBP1, AFF4	sequence-specific DNA binding transcription factor activity [MF]
CG_ffipsc197_promoter_n_RM_12_284_7			3	0.6	1.80E-04	PSRC1, CDCA5, FOXH1, TBX5, PIAS2	negative regulation of androgen receptor signaling pathway [BP], morphogenesis of an epithelium [BP], mitotic metaphase plate congression [BP]
CG_ffipsc197_promoter_n_RM_18_5_1			4	0.4	3.83E-04	RXRG	9-cis retinoic acid receptor activity [MF]
CG_ffipsc197_promoter_n_RM_12_144_6			5	0.8	3.04E-04	SCARB1, CRYGD, FGFR2	fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [BP], fibroblast growth factor receptor signaling pathway involved in hemopoiesis [BP], high-density lipoprotein particle receptor activity [MF], lens fiber cell differentiation [BP], fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow [BP], lens development in camera-type eye [BP], coronal suture morphogenesis [BP]
CG_ffipsc197_promoter_n_RM_12_64_6			5	0.8	4.19E-04	B4GALNT1, ITPK1	inositol tetrakisphosphate 1-kinase activity [MF], inositol-1,3,4-trisphosphate 6-kinase activity [MF], (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity [MF], inositol-1,3,4-trisphosphate 5-kinase activity [MF]
CG_ffipsc197_promoter_n_RM_14_17_1			2	0.4	3.99E-05	ATP4B	hydrogen:potassium-exchanging ATPase activity [MF]
CG_ffipsc197_promoter_n_RM_12_104_9			6	0.8	4.95E-04	ANAPC7	protein phosphatase binding [MF]
CG_ffipsc197_promoter_n_RM_12_67_3			4	0.6	8.79E-05	PGGT1B, EDNRB, TOR1A, PNPLA7, RERE	nuclear membrane [CC], enteric smooth muscle cell differentiation [BP], CAAX-protein geranylgeranyltransferase complex [CC], poly-glutamine tract binding [MF], endothelin receptor signaling pathway [BP]
CG_ffipsc197_promoter_n_RM_12_16_5			5	0.8	3.60E-04	ATP8B1, EZH2, NFIB, TBX3	negative regulation of mesenchymal cell proliferation involved in lung development [BP], atrioventricular bundle cell differentiation [BP], cerebellar mossy fiber [CC], negative regulation of transcription, DNA-dependent [BP], negative regulation of epithelial cell proliferation involved in lung morphogenesis [BP], sinoatrial node cell development [BP]
CG_ffipsc197_promoter_n_RM_12_251_14			4	0.6	3.86E-04	SGPP1	sphinganine-1-phosphate metabolic process [BP], sphingosine-1-phosphate phosphatase activity [MF]
CG_ffipsc197_promoter_n_RM_12_70_8			6	1.0	4.03E-04	AES, TFAP2A, LMO1, ASCL2, SUN2, FOXL2, PITX2, LMNB2	extraocular skeletal muscle development [BP], negative regulation of transcription from RNA polymerase II promoter [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF], nuclear inner membrane [CC], RNA polymerase II transcription coactivator activity [MF], embryonic camera-type eye development [BP], negative regulation of transcription, DNA-dependent [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription [MF], RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription [MF], negative regulation of gene expression [BP], embryonic eye morphogenesis [BP]
CG_ffipsc197_promoter_n_RM_12_194_7			9	1.0	1.93E-04	AARS	hair follicle development [BP]
CG_ffipsc197_promoter_n_RM_14_22_4			3	0.6	1.51E-04	MKX, WNT4	positive regulation of collagen biosynthetic process [BP]
CG_ffipsc197_promoter_n_RM_12_196_6			9	1.0	2.06E-04	NKX3-2, FOXJ1	pattern specification process [BP], determination of left/right symmetry [BP]
CG_ffipsc197_promoter_n_RM_12_42_4			3	0.6	2.56E-04	TBX20, SALL1, MB21D1, COBL, CDIPT, NCOA6	cyclic-GMP-AMP synthase activity [MF], neural tube closure [BP], CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [MF], cardiac septum development [BP], embryonic heart tube elongation [BP], actin filament network formation [BP], inductive cell-cell signaling [BP], heart development [BP]
CG_ffipsc197_promoter_n_RM_12_277_5			5	0.8	2.97E-04	ADI1	acireductone dioxygenase [iron(II)-requiring] activity [MF]
CG_ffipsc197_promoter_n_RM_12_266_4			4	0.8	1.94E-04	KLK14, KDM5B, PRICKLE1	histone H3-K4 demethylation, trimethyl-H3-K4-specific [BP], seminal clot liquefaction [BP], negative regulation of cardiac muscle cell myoblast differentiation [BP]
CG_ffipsc197_promoter_n_RM_12_243_6			4	0.8	1.74E-04	PRDX3, DBR1, GPLD1	alkyl hydroperoxide reductase activity [MF], GPI anchor release [BP], cellular response to triglyceride [BP], RNA lariat debranching enzyme activity [MF], glycosylphosphatidylinositol phospholipase D activity [MF]
CG_ffipsc197_promoter_n_RM_12_142_3			5	1.0	3.18E-04	PPAP2B	canonical Wnt receptor signaling pathway involved in positive regulation of endothelial cell migration [BP], canonical Wnt receptor signaling pathway involved in positive regulation of wound healing [BP], canonical Wnt receptor signaling pathway involved in positive regulation of cell-cell adhesion [BP]
CG_ffipsc197_promoter_n_RM_12_86_6			5	1.0	2.95E-04	WNT5A, BBC3	positive regulation of thymocyte apoptotic process [BP]
CG_ffipsc197_promoter_n_RM_12_119_3			2	0.4	2.66E-04	FKBP11, PPIL4	peptidyl-prolyl cis-trans isomerase activity [MF]
CG_ffipsc197_promoter_n_RM_18_4_6			4	0.4	3.96E-04	PODXL, RPL35, CELSR1, SIX4	viral infectious cycle [BP], inner ear morphogenesis [BP], epithelial tube formation [BP]
CG_ffipsc197_promoter_n_RM_12_215_7			5	1.0	2.69E-04	TOB1, CERS1, CDX2, ETS1, MED1, CERS2, TGFB1	response to cholesterol [BP], sphingosine N-acyltransferase activity [MF], mammary gland branching involved in thelarche [BP], positive regulation of cell differentiation [BP], response to laminar fluid shear stress [BP], SMAD protein import into nucleus [BP], branch elongation involved in mammary gland duct branching [BP], response to vitamin D [BP], hypothalamus development [BP]
CG_ffipsc197_promoter_n_RM_12_188_11			5	1.0	4.57E-04	ZC3H8, ZCCHC11, RUNX1, ZIC5, KIAA0368, ASCL2, MAPKAP1, PAF1, RXRG, JRK, RRAGD, DEK, HOXA7, HOXA5, HOXA4, FOXL2, ZNF784, ZDHHC1, PIP4K2A, CREBZF	embryonic skeletal system morphogenesis [BP], DNA binding [MF], peripheral nervous system development [BP], regulation of transcription, DNA-dependent [BP], stem cell differentiation [BP], sequence-specific DNA binding transcription factor activity [MF], transcription, DNA-dependent [BP], sequence-specific DNA binding [MF], stem cell maintenance [BP], nucleic acid binding [MF], myeloid cell differentiation [BP], pattern specification process [BP], hemopoiesis [BP], negative regulation of myeloid cell differentiation [BP], nucleus [CC]
CG_ffipsc197_promoter_n_RM_12_97_14			4	0.6	2.01E-04	ETS1, RORC, TBX3	sequence-specific DNA binding [MF]
CG_ffipsc197_promoter_n_RM_12_52_11			5	0.8	2.13E-04	TNIP1, USP4, JOSD2	ubiquitin-specific protease activity [MF]
CG_ffipsc197_promoter_n_RM_12_150_10			4	0.8	3.02E-04	B4GALNT1, SATB1, CASP6	cellular component disassembly involved in execution phase of apoptosis [BP], (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity [MF]
CG_ffipsc197_promoter_n_RM_12_217_7			4	0.8	2.70E-04	EPHA2, NKX3-1, HOXB5, HOXA5	embryonic skeletal system morphogenesis [BP], mammary gland epithelial cell proliferation [BP], branching morphogenesis of an epithelial tube [BP], skeletal system development [BP]
CG_ffipsc197_promoter_n_RM_12_115_5			4	0.6	2.89E-04	GANAB, PHF21A, HDAC4, TMEM123, SLC30A3	histone deacetylase complex [CC], oncosis [BP], zinc transporting ATPase activity [MF], glucosidase II complex [CC], glucan 1,3-alpha-glucosidase activity [MF]
CG_ffipsc197_promoter_n_RM_12_270_4			4	0.6	3.50E-04	CKB, MYO1D, LATS2, KIF13A, JAK1, PIP4K2B, TWF1	ATP binding [MF]
CG_ffipsc197_promoter_n_RM_12_152_6			3	0.6	3.48E-04	RNH1, NCBP2, UBC, ETF1	hypothalamus gonadotrophin-releasing hormone neuron development [BP], mRNA catabolic process [BP], RNA metabolic process [BP]
CG_ffipsc197_promoter_n_RM_12_109_6			5	1.0	5.40E-04	GLI3	lambdoid suture morphogenesis [BP], sagittal suture morphogenesis [BP], lateral semicircular canal development [BP], lateral ganglionic eminence cell proliferation [BP], anterior semicircular canal development [BP]
CG_ffipsc197_promoter_n_RM_12_92_7			4	0.8	3.11E-04	RNASET2	ribonuclease T2 activity [MF]
CG_ffipsc197_promoter_n_RM_12_198_4			3	0.6	2.05E-04	CYP11A1, SLC30A1, RAB3A, USP28, BBC3	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [BP], maintenance of presynaptic active zone structure [BP], negative regulation of zinc ion transmembrane import [BP], response to genistein [BP]
CG_ffipsc197_promoter_n_RM_12_226_7			2	0.4	3.97E-04	ADCY6, SALL1, NCOR1, RAB11FIP2	histone deacetylase complex [CC], histone deacetylation [BP], water transport [BP]
CG_ffipsc197_promoter_n_RM_12_219_5			4	0.8	2.72E-04	VAX1, RUNX3, ZFHX2, SCAND1, PURB, STRN3, ZNF3	sequence-specific DNA binding transcription factor activity [MF]
CG_ffipsc197_promoter_n_RM_14_41_3			5	0.6	2.76E-04	B4GALNT1, PTGR1, SALL1	2-alkenal reductase [NAD(P)] activity [MF], (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity [MF], inductive cell-cell signaling [BP]
CG_ffipsc197_promoter_n_RM_12_94_5			5	1.0	3.75E-04	DPM3, FGL1, ROCK2, IDI1	response to stilbenoid [BP], protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [BP], positive regulation of centrosome duplication [BP]
CG_ffipsc197_promoter_n_RM_12_170_5			3	0.6	3.71E-04	INSRR, IPMK	cellular response to alkalinity [BP], inositol tetrakisphosphate 3-kinase activity [MF], inositol-1,4,5-trisphosphate 6-kinase activity [MF]
CG_ffipsc197_promoter_n_RM_12_124_4			3	0.6	1.78E-04	ICA1, RPS6KA5	histone H2A-S1 phosphorylation [BP], secretory granule membrane [CC]
CG_ffipsc197_promoter_n_RM_12_123_12			5	1.0	4.06E-04	KLHL3, KLHL21	Cul3-RING ubiquitin ligase complex [CC]
CG_ffipsc197_promoter_n_RM_12_222_3			3	0.6	4.26E-04	BCAT2, STAT5B	isoleucine metabolic process [BP], valine metabolic process [BP], isoleucine catabolic process [BP]
CG_ffipsc197_promoter_n_RM_14_2_8			6	0.8	7.05E-04	CNOT7, OXER1	5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], CCR4-NOT complex [CC], 5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], 5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF]
CG_ffipsc197_promoter_n_RM_12_203_4			3	0.6	3.34E-04	ABCB6, ICMT, SORT1	protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF], heme-transporting ATPase activity [MF], neurotensin receptor activity, non-G-protein coupled [MF]
CG_ffipsc197_promoter_n_RM_12_1_5			3	0.6	3.52E-04	SOCS3	placenta blood vessel development [BP]
CG_ffipsc197_promoter_n_RM_12_236_5			3	0.6	2.65E-04	ITGB7, ITGB5	integrin complex [CC]
CG_ffipsc197_promoter_n_RM_12_128_5			4	0.8	3.71E-04	SIX1, TACSTD2	negative regulation of branching involved in ureteric bud morphogenesis [BP]
CG_ffipsc197_promoter_n_RM_12_268_4			3	0.6	2.22E-04	ALDH9A1, IMPAD1	4-trimethylammoniobutyraldehyde dehydrogenase activity [MF], aminobutyraldehyde dehydrogenase activity [MF], 3'-nucleotidase activity [MF], 1-pyrroline dehydrogenase activity [MF]
CG_ffipsc197_promoter_n_RM_12_103_6			6	0.8	2.88E-04	GCLM, SIX1, SIX2, CTSL2, CDK5RAP1	protein complex binding [MF], embryonic cranial skeleton morphogenesis [BP], positive regulation of glutamate-cysteine ligase activity [BP], middle ear morphogenesis [BP]
CG_ffipsc197_promoter_n_RM_12_6_9			3	0.4	2.64E-04	ADH5, TSHZ3	respiratory system process [BP], musculoskeletal movement [BP]
CG_ffipsc197_promoter_n_RM_12_53_12			2	0.4	3.47E-04	USP44, USP46, HOXA13, TAF9, USP45, USP32, LECT1	ubiquitin-dependent protein catabolic process [BP], cysteine-type peptidase activity [MF], endothelial cell morphogenesis [BP], negative regulation of proteasomal ubiquitin-dependent protein catabolic process [BP], positive regulation of response to cytokine stimulus [BP], protein deubiquitination [BP], ubiquitin thiolesterase activity [MF]
CG_ffipsc197_promoter_n_RM_12_62_9			6	1.0	3.79E-04	CENPV, POU4F1	habenula development [BP], centromeric heterochromatin assembly [BP], ventricular compact myocardium morphogenesis [BP], proprioception involved in equilibrioception [BP]
CG_ffipsc197_promoter_n_RM_12_101_7			4	0.8	3.10E-04	ECHDC1, TNIP1	methylmalonyl-CoA decarboxylase activity [MF], modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade [BP]
CG_ffipsc197_promoter_n_RM_12_4_6			6	0.8	1.95E-04	SIK1	anoikis [BP]
CG_ffipsc197_promoter_n_RM_12_237_6			2	0.4	2.82E-04	CTPS2, NME3, AKT1	pyrimidine nucleotide metabolic process [BP], CTP biosynthetic process [BP], glycogen cell differentiation involved in embryonic placenta development [BP]
CG_ffipsc197_promoter_n_RM_12_13_5			2	0.4	3.56E-04	COMMD6, IRS2, TP53BP2, AKT2	negative regulation of plasma membrane long-chain fatty acid transport [BP], positive regulation of glycogen biosynthetic process [BP], NF-kappaB binding [MF], positive regulation of fatty acid beta-oxidation [BP]
CG_ffipsc197_promoter_n_RM_12_186_6			3	0.6	3.53E-04	CDK5	acetylcholine receptor activator activity [MF]
CG_ffipsc197_promoter_n_RM_18_2_1			1	0.2	1.95E-04	ZNF681, ZNF737, ZNF708, ZNF506, ZNF117	transcription, DNA-dependent [BP], DNA binding [MF], regulation of transcription, DNA-dependent [BP], zinc ion binding [MF]
CG_ffipsc197_promoter_n_RM_12_47_4			2	0.4	2.25E-04	MTNR1A, LSM4	melatonin receptor activity [MF], U6 snRNP [CC]
CG_ffipsc197_promoter_n_RM_12_178_5			3	0.6	7.68E-05	RUNX1, SFRP4, CNTFR	positive regulation of progesterone secretion [BP], CNTFR-CLCF1 complex [CC], negative regulation of sodium-dependent phosphate transport [BP], sex differentiation [BP]
CG_ffipsc197_promoter_n_RM_12_18_4			3	0.4	2.59E-04	PRKAR1B, HCN4	cAMP binding [MF]
CG_ffipsc197_promoter_n_RM_12_17_4			4	0.8	4.32E-04	SRSF7, BARD1, CDKN1C, HYAL2, SOX15, OTX2, EBF2, FANCA, WT1	negative regulation of metanephric glomerular mesangial cell proliferation [BP], positive regulation of transcription, DNA-dependent [BP], kidney development [BP], gonad development [BP], negative regulation of mRNA 3'-end processing [BP], male gonad development [BP], transcription from RNA polymerase II promoter [BP], receptor signaling protein tyrosine kinase inhibitor activity [MF], regulation of transcription from RNA polymerase II promoter [BP]
CG_ffipsc197_promoter_n_RM_14_13_2			3	0.4	1.05E-04	SNUPN	snRNA import into nucleus [BP]
CG_ffipsc197_promoter_n_RM_14_36_12			10	0.8	4.72E-04	PRKRIR, COL11A2, DDHD1, PPTC7, MGAT1, RELN, ECE1, ALKBH4, PTGS2	metal ion binding [MF]
CG_ffipsc197_promoter_n_RM_12_207_5			4	0.8	2.42E-04	ACAA1, ACAA2	acetyl-CoA C-acyltransferase activity [MF]
CG_ffipsc197_promoter_n_RM_12_5_6			3	0.6	4.56E-04	ALDH4A1, HOXA1, ALAD	optokinetic behavior [BP], abducens nerve formation [BP], porphobilinogen synthase activity [MF], 1-pyrroline-5-carboxylate dehydrogenase activity [MF], lead ion binding [MF]
CG_ffipsc197_promoter_n_RM_12_208_5			9	1.0	2.79E-04	NGF, TPMT, RAB3A, ARHGDIA, SCRIB	regulation of neurotransmitter secretion [BP], thiopurine S-methyltransferase activity [MF], cellular component movement [BP], positive regulation of axonogenesis [BP], synaptic vesicle endocytosis [BP], neurotransmitter secretion [BP], nerve growth factor receptor binding [MF], response to electrical stimulus [BP], synaptic vesicle exocytosis [BP]
CG_ffipsc197_promoter_n_RM_12_234_4			3	0.6	2.61E-04	OTX2, WNT11	endoderm development [BP]
CG_ffipsc197_promoter_n_RM_14_18_2			2	0.4	2.22E-04	CLN3	lysosomal lumen pH elevation [BP], globoside metabolic process [BP], autophagic vacuole fusion [BP]
CG_ffipsc197_promoter_n_RM_12_133_9			5	0.8	3.97E-04	ADAMTS1, FGFR1, PTCH1	renal system development [BP], heparin binding [MF]
CG_ffipsc197_promoter_n_RM_12_283_4			5	0.8	3.00E-04	PEMT, B4GALNT1, LUZP1	neural fold bending [BP], (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity [MF], phosphatidylethanolamine N-methyltransferase activity [MF], phosphatidyl-N-methylethanolamine N-methyltransferase activity [MF], phosphatidyl-N-dimethylethanolamine N-methyltransferase activity [MF]
CG_ffipsc197_promoter_n_RM_12_201_3			5	0.8	1.06E-04	APTX, NOP14, CELSR1, NR3C1	Noc4p-Nop14p complex [CC], protein localization involved in establishment of planar polarity [BP], glucocorticoid receptor activity [MF], DNA 5'-adenosine monophosphate hydrolase activity [MF]
CG_ffipsc197_promoter_n_RM_12_3_5			3	0.6	2.94E-04	MGAT1, OPLAH, FGF8, PODXL	5-oxoprolinase (ATP-hydrolyzing) activity [MF], cell migration involved in mesendoderm migration [BP], regulation of microvillus assembly [BP], alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], UDP-N-acetylglucosamine catabolic process [BP]
CG_ffipsc197_promoter_n_RM_12_105_5			6	0.8	2.54E-04	PKD1, PITPNA, RPS6KA5, SCN3B, TRPC3	axon guidance [BP], detection of mechanical stimulus [BP]